I'm trying to break into biotech ER. I recently passed the SIE and am considering series 63 next. Would having the series 63 help with the job search or should I wait until I get a job? I'm also considering CFA but heard mixed opinions about it. Any suggestions?
| +13 | Is Equity Research Dying - Where Are the Future Opportunites? | 4 | 1d |
| +10 | Associates who stuck around for > 5 years working for the same analyst. Why? | 4 | 6d |
| +9 | UBS ER SA27 Superday | 7 | 3w |
| +9 | Detailed Revenue and Cost Builds | 3 | 1w |
| +7 | Analyst with no coverage or ranking | 5 | 1w |
| +7 | Uiuc or Ross or UChicago | 8 | 2w |
| +1 | IB SA -> ER FT | 4 | 2w |
| 0 | Equity Research Rankings | 1 | 1w |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
CFA would help although it is a big time commitment and networking/outreach would likely be a better use of time for breaking in to research.
I don't think the 63 would help at all.
Thanks! I have been networking and reaching out to people. I agree that CFA is a huge time and cost commitment but I'm leaning towards it because it might come in handy if I ever want to move out of US.
Sunt temporibus dolorem nulla inventore ad sed facere et. Ut commodi sit temporibus. Ut maiores qui impedit.
Omnis ab tempora veniam aspernatur sed dolore. Ut ut harum beatae tempore earum maxime porro doloremque. Porro sint et ipsum ea ratione eaque quo.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...